Federal contract award

W81K0225PA023

VASCULAB GSX, BRAND NAME OR EQUAL, NON-INVASIVE PHYSIOLOGIC TESTING SYSTEM DESIGNED TO EVALUATE PERIPHERAL ARTERY DISEASE (PAD).

Research the contractorView USAspending sourceSave to my pursuit research

Award details

Obligations, current value and potential value describe different measures; they are never added together.

FieldReported value
AgencyDepartment of Defense
OfficeDEFENSE HEALTH AGENCY HCD WEST
NAICS339112 — Surgical and Medical Instrument Manufacturing
PSC6515 — Medical and Surgical Instruments, Equipment, and Supplies
Parent award / vehicleNot reported
Set-asideSMALL BUSINESS SET ASIDE - TOTAL
Pricing typeFIRM FIXED PRICE
Obligations$43.9K
Current contract value$43.9K
Potential contract value / ceiling$43.9K
Start dateMay 27, 2025
Current end dateJul 22, 2025
Potential end dateJul 22, 2025
Latest award activityJun 2, 2026
Source loadedSep 26, 2026

Funding and modification history

Showing the latest 3 of 3 loaded transactions. Negative values are deobligations.

DateModificationObligation changeDescription
Jun 2, 2026P00002$0NON-INVASIVE PHYSIOLOGIC TESTING SYSTEM DESIGNED TO EVALUATE PERIPHERAL ARTERY DISEASE
Apr 6, 2026P00001$0VASCULAB GSX, BRAND NAME OR EQUAL, NON-INVASIVE PHYSIOLOGIC TESTING SYSTEM DESIGNED TO EVALUATE PERIPHERAL ARTERY DISEASE (PAD).
May 22, 20250$43.9KVASCULAB GSX, BRAND NAME OR EQUAL, NON-INVASIVE PHYSIOLOGIC TESTING SYSTEM DESIGNED TO EVALUATE PERIPHERAL ARTERY DISEASE (PAD).

Research next steps

  1. Check the stated set-aside against the solicitation and current certifications.
  2. Review the award scope and buyer evidence before making a bid/no-bid decision.